T-SPOT.TB resources people talking

News

Latest News

29 Sep 2020
Oxford Immunotec Announces Food and Drug Administration (FDA) Clearance of the T-SPOT®.TB Test for Use in Pediatrics Over the Age of Two

READ MORE

20 Sep 2020
Oxford Immunotec Joins Forces with Public Health England (PHE) in a Large Clinical Trial Utilizing T-SPOT® Discovery™ SARS-CoV-2 Test


READ MORE

20 Jul 2020
Oxford Immunotec Announces Agreement with Stop TB Partnership – Global Drug Facility (GDF) to Provide Access to the T-SPOT®.TB Test for 100+ TB Burden Countries

READ MORE

19 May 2020
Oxford Immunotec releases the T-SPOT® DiscoveryTM SARS-CoV-2 kit for research into measuring the T cell immune response to SARS-CoV-2, which may offer new insights into immunity to COVID-19

READ MORE

20 Feb 2020
Oxford Immunotec Announces New Data on the Utility of T-SPOT®.CMV in Kidney and Stem Cell Transplant


READ MORE

17 May 2019
Oxford Immunotec Welcomes Updated CDC Recommendations for Tuberculosis Screening and Testing of Healthcare Personnel


READ MORE


Page : 1 | 2 | 3 | 4 | 5 | Prev | Next